Home›Cardiology› AI research in aortic valve disease surges, focusing on diagnosis and risk stratification
AI research in aortic valve disease surges, focusing on diagnosis and risk stratificationArtificial Intelligence Shows Growth in Aortic Valve Disease Research
Frontiers in MedicinePublished July 10, 2026DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Interpret this scientometric review as evidence of growing AI research in aortic valve disease, not as clinical practice guidance.
This systematic review provides a scientometric analysis of 270 articles on artificial intelligence (AI) in aortic valve disease, including aortic stenosis. The study examines publication trends, research hotspots, and keyword clustering to map the evolution of AI applications in this field.
Annual publications increased steadily, with the United States leading in output and influence. Research hotspots centered on AI-assisted diagnosis, risk stratification, and prognosis prediction for aortic stenosis. Keyword clustering revealed themes such as disease diagnosis, therapeutic technologies, AI-enabled applications, and clinical outcomes.
The review does not report pooled effect sizes or comparative outcomes, as it is a narrative and scientometric analysis rather than a clinical trial. Limitations are not explicitly stated in the abstract, but the authors note that results reflect trends in published literature rather than direct clinical evidence.
For clinicians, this review underscores the rapid advancement of AI in aortic valve disease and suggests prioritizing multimodal models and clinical integration. However, the findings are descriptive and do not provide direct evidence for clinical decision-making.
How this fits prior evidence
This systematic review of AI in aortic valve disease extends prior coverage by mapping the research landscape, complementing earlier findings on aortic valve interventions. While prior items focused on clinical outcomes of early intervention, TAVR techniques, and mortality comparisons, this review highlights AI's emerging role in diagnosis and risk stratification, addressing a gap in understanding technological trends. It does not directly confirm or contrast prior clinical results.
A review of 270 articles looked at how artificial intelligence, specifically machine learning and deep learning, is being used to study aortic valve disease. The analysis focused on the trends in scientific literature rather than testing these tools directly on patients.
The findings show a steady increase in research publications every year. Most of this work comes from the United States. Researchers are currently using these technologies to help with diagnosis, predicting patient risks, and forecasting outcomes for those with aortic stenosis.
Because this was a review of existing papers and not a clinical trial, the results do not provide direct proof that AI improves patient care yet. It shows that the field is moving quickly toward using complex models to help doctors manage heart conditions. You should talk to your doctor about how these new technologies might affect your specific treatment plan.
What this means for you:
Research shows a growing trend in using artificial intelligence to help diagnose and predict aortic valve disease.
Common questions
How is artificial intelligence being used for heart conditions?
Artificial intelligence, including deep learning and machine learning, is being used in research to help with diagnosis, risk stratification, and prognosis prediction for patients with aortic stenosis. These tools are part of a growing trend in medical literature to improve how doctors identify and manage the disease.
Is artificial intelligence currently used to treat aortic valve disease?
The study analyzed 270 articles to track research trends rather than clinical outcomes. While it shows that AI is being developed for diagnosis and risk prediction, this review does not provide evidence on how these tools are used in daily clinical treatments or patient care.
BackgroundAortic valve disease, particularly aortic stenosis, poses a growing global health burden with aging populations. Artificial intelligence technology offers promising tools for diagnosis, risk stratification, and prognosis prediction, yet the knowledge structure of this interdisciplinary field remains unsystematically characterized.ObjectiveThis study aims to conduct a scientometric analysis to delineate the research landscape, identify hotspots, and trace evolutionary trends of AI technology applications in aortic valve disease over the past decade.MethodsWe retrieved relevant literature published between January 2016 and January 2026 from the Web of Science Core Collection and Scopus databases. After screening, 270 eligible articles were included. CiteSpace and VOSviewer were employed to perform visualization analyses of authors, institutions, countries, journals, keywords, and co-citation networks.ResultsAnnual publications increased steadily, with the United States leading in both output and influence. The Mayo Clinic emerged as the most prolific institution. Research hotspots focused on AI-assisted diagnosis, risk stratification, and prognosis prediction for aortic stenosis, primarily using deep learning and machine learning techniques. Keyword clustering revealed themes spanning disease diagnosis, therapeutic technologies, AI-enabled applications, and clinical outcomes. Co-citation analysis highlighted key studies on AI-enhanced electrocardiography and echocardiography for valve disease detection.ConclusionsAI technology research in aortic valve disease is advancing rapidly. Based on the keyword clustering and timeline analysis, we propose a conceptual mapping of AI techniques onto clinical phases. Future efforts should prioritize developing multimodal models, facilitating clinical integration, and enhancing patient lifecycle management.
